Belite Bio, Inc (BLTE) Social Stream
BELITE BIO INC (BLTE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BLTE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-01 | 2 | $57 | $57 | $57 | $40.71 | 40.01% |
| 2023-04-04 | 2 | $58 | $57 | $57.5 | $40.71 | 41.24% |
| 2023-07-25 | 2 | $57 | $55 | $56 | $40.71 | 37.56% |
| 2023-07-28 | 4 | $57 | $25 | $45.666 | $40.71 | 12.17% |
| 2023-10-08 | 4 | $57 | $25 | $45 | $40.71 | 10.54% |
| 2023-11-06 | 4 | $59 | $25 | $46 | $40.71 | 12.99% |
| 2023-11-07 | 4 | $59 | $43 | $51 | $40.71 | 25.28% |
| 2023-11-15 | 5 | $59 | $45 | $53.666 | $40.71 | 31.83% |
The Trend in the Analyst Price Target
BLTE's average price target has moved down $3.83 over the prior 14 months.
BLTE reports an average of 99.53% for its upside potential over the past 38 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-04 | 2 | 58 | 57 | 57.5 | 30.00 | 91.67% |
| 2023-06-05 | 2 | 57 | 55 | 56.0 | 15.50 | 261.29% |
| 2023-08-10 | 4 | 57 | 25 | 45.0 | 24.50 | 83.67% |
| 2023-11-06 | 4 | 59 | 25 | 46.0 | 39.23 | 17.26% |
| 2023-11-07 | 4 | 59 | 43 | 51.0 | 40.10 | 27.18% |
BLTE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 52 weeks, BLTE's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, BELITE BIO INC's number of analysts covering the stock is higher than 102.97% of them.
- BELITE BIO INC's variance in analysts' estimates is lower than -228.41% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, BELITE BIO INC's average analyst price target is higher than 1008.84% of them.
- BELITE BIO INC's upside potential (average analyst target price relative to current price) is higher than 286.18% of Pharmaceutical Products stocks.
Stocks similar to BELITE BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PEPG, THRD, and MLYS.
View All Top Stocks by Price Target
Is BLTE a Buy, Hold or Sell? See the POWR Ratings now!